MultiplexDX is a biotech diagnostics company, developing accurate, specific, quantifiable, and affordable diagnostic tests. It aims to provide effective and successful treatment of tumors and prevent cancer. To achieve this, the company is in the phase of developing a new visualization technology combining the approach of molecular biology and histopathological methods. This technology has an ambition to surpass the limitations of existing medical diagnostic and prognostic methods and to take a key role in this fast-changing market.
MultiplexDX operates from Kosice, Slovakia and Maryland, US and is currently serving first clients on both European and US markets.